Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1

EMBO Journal

Volumn 18, Issue 20, 1999, Pages 5755-5760

  Sugawara, Yasuhiko ^a,b   Makuuchi, Masatoshi ^b   Kato, Nobuyuki ^c   Shimotohno, Kunitada ^d   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

EBNA1; Epstein Barr virus; Hepatitis C virus; Hepatocellular carcinoma; Transactivation

Indexed keywords

CELL NUCLEUS ANTIGEN;

ARTICLE; BURKITT LYMPHOMA; CELL STRAIN HEPG2; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSACTIVATION; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE DELETION; GENES, VIRAL; HELPER VIRUSES; HEPACIVIRUS; HERPESVIRUS 4, HUMAN; HUMANS; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 0033570165     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.20.5755     Document Type: Article

References (32)

1. Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I. and Knowles, B.B. (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615-616.
2. Berns, K.I. (1996) Parvoviridae: the viruses and their replication. In Fields, B.N., Knipe, D.M. and Howley, P.M. (eds), Fields Virology, 3rd edn. Lippincott-Raven, Philadelphia, PA, pp. 2173-2198.
3. Choo, Q.-L., Kuo, A., Weiner, A.J., Overby, L.R., Bradly, D.W. and Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359-362.
4. Grässer, F.A. et al. (1994) Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood, 84, 3792-3798.
5. Imai, S., Nishikawa, J. and Takada, K. (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol., 72, 4371-4378.
6. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. and Shimotohno, K. (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl Acad. Sci. USA, 87, 9524-9528.
7. Kirchmaier, A.L. and Sugden, B. (1997) Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol., 71, 1766-1775.
8. Komano, J., Sugiura, M. and Takada, K. (1998) Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J. Virol., 72, 9150-9156.
9. Kuo, G. et al. (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science, 244, 362-364.
10. Mackey, D. and Sugden, B. (1999) The linking regions of EBNA1 are essential for its support of replication and transcription. Mol. Cell. Biol., 19, 3349-3359.
11. Margolskee, R.F., Kavathas, P. and Berg, P. (1988) Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol. Cell. Biol., 8, 2837-2847.
12. Markin, R.S. (1994) Manifestations of Epstein-Barr virus-associated disorders in liver. Liver, 14, 1-13.
13. Middleton, T. and Sugden, B. (1994) Retention of plasmids DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol., 68, 4067-4071.
14. Miyoshi, J., Kubonishi, I., Toshimoto, S., Akagi, T., Ohtuki, Y., Shiraishi, Y., Nagata, K. and Hinuma, Y. (1981) Type C retrovirus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature, 296, 770-771.
15. Mizutani, T., Kato, N., Saitoh, S., Ikeda, M., Sugiyama, K. and Shimotohno, K. (1996) Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type I-infected cell line, MT-2. J. Virol., 70, 7219-7223.
16. Ohkoshi, S. et al. (1990) Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J. Cancer Res., 81, 550-553.
17. Rawlins, D.R., Milman, G., Hayward, S.D. and Hayward, G.S. (1985) Sequence specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell, 42, 859-868.
18. Reisman, D. and Sugden, B. (1986) Transactivation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr virus nuclear antigen 1. Mol. Cell. Biol. 6, 3838-3846.
19. Rice, C.M. (1996) Flaviviridae: the viruses and their replication. In Fields, B.N., Knipe, D.M. and Howley, P.M. (eds), Fields Virology, 3rd edn. Lippincott-Raven, Philadelphia, PA, pp. 931-960.
20. Rickinson, A.B. and Kieff, E. (1996) Epstein-Barr virus. In Fields, B.N., Knipe, D.M. and Howley, P.M. (eds), Fields Virology, 3rd edn. Lippincott-Raven, Philadelphia, PA, pp. 2397-2446.
21. Sadler, R.H. and Raab-Traub, N. (1995) Structural analysis of the Epstein-Barr virus BamHI A transcripts. J. Virol., 69, 1132-1141.
22. Saito, I. et al. (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 87, 6547-6549.
23. Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y. and Takada, K. (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol., 68, 6069-6073.
24. Shimizu, N., Yoshiyama, H. and Takada, K. (1996) Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J. Virol., 70, 7260-7263.
25. Snudden, D.K., Hearing, J., Smith, P.R., Gässer, F.A. and Griffin, BE. (1994) EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J., 13, 4840-4847.
26. Sugawara, Y., Mizugaki, Y., Uchida, T., Torii, T., Imai, S., Makuuchi, M. and Takada, K. (1999) Detection of EBV in hepatocellular carcinoma tissue: a novel EBV latency characterized by absence of EBER expression. Virology, 10, 196-202.
27. Takada, K. (1984) Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer, 33, 27-32.
28. Takada, K. and Ono, Y. (1989) Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol., 63, 445-449.
29. Yates, J.L. and Camilo, S.M. (1988) Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells, 6, 197-205.
30. Yates, J.L., Warren, N., Reisman, D. and Sugden, B. (1984) A cis-acting element from Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl Acad. Sci. USA, 81, 3806-3810.
31. Yates, J.L., Warren, N. and Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.
32. Yoshiyama, H., Shimizu, N. and Takada, K. (1995) Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J., 14, 3706-3711.